Rheumatoid arthritis treatment applications of non-steroidal anti-inflammatory drugs such as diclofenac sodium enteric solution tablets, celecoxib capsules, etoricoxib tablets, slow-acting anti-rheumatic drugs such as methotrexate, leflunomide, regimen polyglucoside tablets, salazosulfapyridine enteric solution tablets, hydroxychloroquine, etc., have the potential risk of hepatic and renal toxicity and bone marrow suppression, so patients with rheumatoid arthritis need to be reviewed regularly. Rheumatoid arthritis review has two basic purposes: 1, monitoring drug side effects: check the liver and kidney function and blood routine 2, monitoring disease activity: need to check the academic sedimentation, C-reactive protein and rheumatoid factor, anti-CCP antibodies, etc. Review cycle: generally once a month to review, the condition is stable, the longest period of no more than three months.